E-cigarettes as Effective Tools for Smoking Cessation: Study

Sep.08.2022
E-cigarettes as Effective Tools for Smoking Cessation: Study
A recent survey in England shows e-cigarettes to be an effective smoking cessation tool, with teen smoking rates steadily declining.

A recent survey conducted in schools across England has provided further evidence that e-cigarettes are an effective smoking cessation tool.


The UK's National Health Service has released the findings of a survey on the smoking, drinking, and drug use habits of young people in the country. The media has highlighted the report's discovery that from 2018 to 2021, there was a slight increase in the number of youths who use e-cigarettes, rising from 6% to 9%.


According to a report by the BBC, doctors have stated that electronic cigarette companies are targeting children with brightly colored packaging, exotic flavors, and appealing names. An official from the Royal College of Pediatrics and Child Health expressed deep concern to the media about the increasing number of young people using e-cigarettes.


I am also concerned about the use of nicotine by minors. However, upon careful observation, there is some very positive news to be found: the smoking rate amongst young people in England continues to decrease, and e-cigarettes have been a significant contributing factor in this public health victory. This is a cause for celebration no matter where you are, as it adds to the already existing evidence supporting e-cigarettes as a smoking cessation tool.


Electronic cigarettes facilitate smoking cessation.


The survey is conducted biennially among adolescents aged 11 to 15. This special report includes responses from 9,289 participants from 119 schools. Two survey results are particularly noteworthy. Firstly, the majority of adolescents using e-cigarettes are current or former smokers. The report notes that "56% of quitters are currently using e-cigarettes." Additionally, "frequent e-cigarette users who frequently smoke have more than doubled, from 29% in 2018 to 61% in 2021.


This means that electronic cigarettes, which are widely believed to be less harmful than smoking, have helped many young people replace some or all of their cigarette consumption. In other words, the increase in electronic cigarettes largely reflects a decrease in smoking. Nobody wants young people to use nicotine-containing products. However, if they are going to disobey public health rules, as young people tend to do, electronic cigarettes are a less harmful way to rebel.


Please note that only 3% of students were classified as current smokers in the survey, meaning that both e-cigarette and smoking rates in England are relatively low.


Non-smokers do not use electronic cigarettes.


Moving forward, it is equally important to note that few non-smoking adolescents are interested in using e-cigarettes. A survey found that "only 1% of students who have never smoked regularly use e-cigarettes." In addition, "the majority of frequent smokers (92%) reported having used e-cigarettes. In comparison, only 13% of students who have never smoked." These statistical findings should be viewed in light of another number: 88% of survey respondents "are aware of e-cigarettes." Most adolescents are aware of what e-cigarettes are, but do not try them.


Similar results have also been found in studies conducted in the United States. In October, the Centers for Disease Control and Prevention reported that 3% of American high school students use nicotine on a daily basis, with a majority of them smoking prior to trying e-cigarettes. As the authors of the NHS report explain, smoking history (or lack thereof) can often predict an individual's interest in e-cigarettes.


Students who used to smoke are more likely to have used e-cigarettes than students who have never smoked.


While the report did find an increase in current e-cigarette usage, it also revealed that lifetime e-cigarette use did not increase during the study period. In fact, this number actually slightly decreased.


During their lifetime use, no increase in current usage was observed. 22% of students reported having used e-cigarettes, compared to 25% in 2018 (a minimal change).


It should be noted that these results are based on self-reported answers from teenagers, and therefore the data should be interpreted with caution. That being said, if these numbers are entirely accurate, they paint an encouraging picture. Teenage smoking rates in the UK are declining, as they are in the United States.


Disclaimer: 1. This article is compiled from third-party information for industry exchange and learning only. 2. The views expressed in this article do not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity and accuracy of the article's content. The compilation of this article is for industry exchange and research only. 3. Due to limited compilation abilities, the compiled article may not fully reflect the original author's intent. Please refer to the original article for accuracy. 4. For any domestic, Hong Kong, Macao, Taiwan, and foreign-related statements and positions, 2FIRSTS fully aligns with the Chinese government. 5. The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
Juul Sublicense Reshapes Vuse Alto Patent Bill as Court Ends R.J. Reynolds’ 5.25% Royalty Obligation to Altria
Juul Sublicense Reshapes Vuse Alto Patent Bill as Court Ends R.J. Reynolds’ 5.25% Royalty Obligation to Altria
According to Law360 on August 31, 2026, a federal judge in North Carolina ruled that a patent sublicense between R.J. Reynolds Vapor Co. and Juul Labs Inc. relieves Reynolds of its obligation to continue paying royalties to Altria Client Services LLC over Vuse Alto. A jury had previously found that Vuse Alto infringed three Altria patents and awarded approximately $95.2 million in past damages, after which Reynolds was ordered to pay an ongoing royalty equal to 5.25% of positive net sales. The new ruling finds that a valid sublicense can eliminate future infringement, potentially ending what Altria described as hundreds of millions of dollars in future royalties.
Sep.01
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Philip Morris Japan (PMJ) launched the IQOS ILUMA i PRIME Ginza Limited Model Set in Tokyo on September 4, 2026, alongside the opening of IQOS Flagship Ginza, the brand’s first global flagship store. The Oasis Blue edition is limited to 1,814 individually numbered units, with the figure derived from the store’s address at Ginza 1-8-14. The set also includes two Yamanaka-nuri glasses and special packaging, priced at JPY 11,980 and sold exclusively at the Ginza flagship.
Sep.07
Product | JTI Launches Ploom AURA Teal Electric Pop in South Korea, Its First Dual-Color Edition
Product | JTI Launches Ploom AURA Teal Electric Pop in South Korea, Its First Dual-Color Edition
JTI Korea launched the Ploom AURA Teal Electric Pop limited edition in South Korea on September 1, 2026, marking the first dual-color design in the Ploom AURA range. The device combines a dark green body with teal accents and is accompanied by matching Front Panel, Back Cover and Pocket Bag accessories. The standalone device is priced at KRW 29,000, with three additional device-and-accessory bundles available. The release continues JTI Korea's use of limited colorways and interchangeable accessories to expand the Ploom AURA portfolio without introducing a new hardware platform.
Sep.03